scorecardresearch
Friday, August 22, 2025
TopicPharma sector

Topic: Pharma sector

India ceding ground in biopharma innovation, manufacturing — AllianceBernstein’s open letter to PM

Analysts from AllianceBernstein point to four areas where India lags behind its Asian peers and underline that nation finds no mention in global healthcare innovation index.

Cheap alternatives, API imports — why Penicillin G production, set to resume after 30 yrs, declined

Production of PenG, used to treat tetanus, strep infections, syphilis, pneumonia & more, was stopped in India in 1990s after cheaper alternatives began surfacing in global market.

Indian pharma firms now liable to recall defective drugs as Modi govt notifies new norms

Under revised good manufacturing practices (GMP) norms, pharma companies will be required to assume onus for quality of drugs to ensure they do not place patients at risk.

Trade body says Indian pharma exports to hit $27 billion this fiscal, despite cough syrup deaths

India is the world's third largest maker of drugs by volume, and US sales, which account for 30% of total pharma exports, have risen by 6.2% last year.

Una’s bulk drug park is the ‘next Bhakra Nangal’. And it’s BJP’s trump card in Himachal polls

In the homes of BJP supporters, photocopies of the map of the land demarcated for the bulk drug park are doing the rounds.

Haryana firm flagged by WHO after 66 child deaths in Gambia stops making ‘contaminated’ syrups

After an inspection, the Haryana government finds 12 flaws in the manufacturing facility; ‘Action will be taken,’ says Home and Health Minister Anil Vij.

Cough syrups made by Delhi-based Maiden Pharma may be tied to 66 deaths in Gambia, says WHO

In July, alarm was raised in Gambia after several children began falling ill with kidney problems. WHO has issued an alert asking regulators to remove the company's goods from the market.

Apollo, Reliance make $6.3-billion binding offer to buy UK drugstore chain Boots

Walgreens Boots Alliance’s negotiations with Apollo and Reliance currently have the most momentum, said people in the know. Their proposal values Boots at more than £5 billion ($6.3 billion).

Ireland ‘exploring’ tie-up with DU to build bridges in higher education, research collaboration

Conor Fahy of govt agency Enterprise Ireland says such collaboration can ‘deepen FDI’. DU V-C Yogesh Singh says MoU with Irish varsities likely by end of 2022.

India to get 7 million doses of Moderna vaccine, but indemnity puts question mark on when

The central govt has so far procured only vaccines manufactured in India. But Moderna vaccine will be a part of the national vaccination programme.

On Camera

130th Constitution Amendment Bill makes PM, President redundant. It’s a mockery of ministers

The Bill is a frontal attack on the basic federal structure of the Constitution. It shifts governance from ‘rule of law’ to ‘rule by law’.

New insolvency frameworks to shorter timelines, how 2025 amendment bill proposes to transform IBC

New bill aims to fix key issues with IBC 2016, including delays & patchy implementation, and protect creditors, with window for genuine promoters to retain control of their companies.

Indian firm joins hands with US manufacturer to locally develop all-terrain vehicles for armed forces

Under joint venture, JSW Sarbloh Motors will indigenise and manufacture TX range ATVs in Chandigarh. The first India-assembled unit is expected by early 2026.

War of IAF, PAF doctrines: As Pakistan obsesses over numbers, India embraces risk, wins

Now that both IAF and PAF have made formal claims of having shot down the other’s aircraft in the 87-hour war in May, we can ask a larger question: do such numbers really matter?